Table 4 The effects of physical activity substitution on clinical outcomes of MHD patients.
MPA | VPA | MPA | VPA | ||
---|---|---|---|---|---|
All | GNRI ≥ 92 Age < 65 | ||||
Outcomes | 1.000 (0.9976–1.003) | 1.004 (1.000–1.009) | 1.000 (0.996–1.004) | 1.004 (1.000–1.008) | |
All-cause death | 1.001 (0.997–1.005) | 0.998 (0.990–1.007) | 1.001 (0.997–1.006) | 0.998 (0.990–1.007) | |
MACE | 1.000 (0.997–1.004) | 1.004 (1.000–1.009) | 1.000 (0.997–1.004) | 1.004 (1.000–1.008) | |
Heart failure | 1.001 (0.998–1.004) | 1.004 (1.000–1.007)* | 0.998 (0.994–1.003) | 1.002 (0.998–1.005) | |
Stroke | 1.002 (0.995–1.005) | 1.002 (0.998–1.006) | 1.009 (1.000–1.018)* | 1.010 (1.002–1.018)* | |
Myocardial infarction | 0.999 (0.993–1.005) | 0.999 (0.992–1.006) | – | – | |
Atrial fibrillation | 0.992 (0.972–1.012) | – | 0.999 (0.980–1.019) | – | |
Tumor | 1.002 (0.991–1.012) | – | – | – |